WASATCH ADVISORS LP – Atara Biotherapeutics, Inc. Transaction History
WASATCH ADVISORS LP portfolio value:
$30.75M
portfolio value
WASATCH ADVISORS LP quarter portfolio value change:
-51.48%
quarter
Atara Biotherapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +58.70% | 3.00M shares | -9.18M | $3.78 | 8.13M |
| Q2 2022 | share | Increase | +34.08% | 1.30M shares | 4.41M | $7.79 | 5.12M |
| Q1 2022 | share | Increase | +88.77% | 1.79M shares | 3.59M | $9.29 | 3.82M |
| Q4 2021 | share | Decrease | -30.34% | -881.99K shares | -20.12M | $16.12 | 2.02M |
| Q3 2021 | share | Increase | +21.74% | 519.27K shares | 14.90M | $17.9 | 2.90M |
| Q2 2021 | share | Increase | +17.53% | 356.29K shares | 7.95M | $15.55 | 2.38M |
| Q1 2021 | share | Increase | +2.82% | 55.79K shares | -9.61M | $14.36 | 2.03M |
| Q4 2020 | share | Decrease | -27.71% | -757.32K shares | 3.36M | $19.63 | 1.97M |
| Q3 2020 | share | Increase | +391.37% | 2.17M shares | 27.32M | $12.96 | 2.73M |
| Q2 2020 | share | Increase | +298.07% | 416.54K shares | 6.91M | $14.57 | 556.3K |
| Q1 2020 | share | Decrease | -87.31% | -961.35K shares | -16.94M | $8.51 | 139.75K |
| Q4 2019 | share | Increase | +62.69% | 424.29K shares | 8.57M | $16.47 | 1.10M |
| Q3 2019 | share | Increase | +11.79% | 71.37K shares | -2.61M | $14.12 | 676.81K |
| Q2 2019 | share | Increase | +41.85% | 178.63K shares | -4.79M | $20.11 | 605.43K |
| Q1 2019 | share | Increase | +21.89% | 76.64K shares | 4.80M | $39.75 | 426.80K |
| Q4 2018 | share | Increase | +2354.88% | 335.9K shares | 11.57M | $34.74 | 350.16K |
| Q3 2018 | share | Decrease | -8.17% | -1.26K shares | 19K | $41.35 | 14.26K |
| Q2 2018 | share | Increase | +53.20% | 5.39K shares | 176K | $36.75 | 15.53K |
| Q1 2018 | share | Increase | 0.00% | 10.13K shares | 395K | $39 | 10.13K |